Yohei Tateishi1, Yuji Ueno2, Ryosuke Doijiri3, Ayako Kuriki4, Takahiro Shimizu5, Muneaki Kikuno6, Yoshiaki Shimada7, Hidehiro Takekawa8, Masatoshi Koga9, Yuki Kamiya4, Koichi Hirata8, Kazunori Toyoda9, Yasuhiro Hasegawa5, Nobutaka Hattori2, Takao Urabe7, Akira Tsujino1 (1.Department of Neurology and Strokology, 2.Department of Neurology, Juntendo University Faculty of Medicine, 3.Department of Neurology, Iwate Prefectural Central Hospital, 4.Department of Neurology, Showa University Koto Toyosu Hospital, 5.Department of Neurology, St. Marianna University School of Medicine, 6.Department of Neurology, Tokyo Medical University Hospital, 7.Department of Neurology, Juntendo University Urayasu Hospital, 8.Department of Neurology, Dokkyo Medical University, 9.Department of Cerebrovascular Medicine, National Cerebral and Cardiovascular Center Hospital)
Session information
Oral Session
[O-32] Cerebrovascular disease (Clinical research 3)
Fri. May 24, 2019 9:45 AM - 11:15 AM Room 9 (Osaka International Convention Center 12F Conference Hall)
Chair:Shigeru Fujimoto(Division of Neurology, Department of Medicine, Jichi Medical University)
Koichiro Nagai1, Takashi Shimoyama1, Satoshi Suda1, Yasuhiro Nishiyama1, Kazumi Kimura1, Hiroki Yamaguchi2, Koichi Inokuchi2 (1.Department of Neurological Science, Nippon Medical School, 2.Department of Hematology, Nippon Medical School)
Tesseki Izumi, Naohiko Iguchi, Maki Ozaki, Hitoki Nanaura, Kazuma Sugie (Department of Neurology, Nara Medical University)
Naoko Sumi1, Takemori Yamawaki1, Taku Taduma1, Roi Ishikawa1, Masahiro Hayashi1, Haruka Ishibashi1, Takamichi Sugimoto1, Eiichi Nomura1, Katsumi Kurokawa2 (1.Hiroshima City Hiroshima Citizens Hospital, 2.Brain Attack Center Ota Memorial Hospital)
Taku Tazuma, Roy Ishikawa, Masahiro Hayashi, Naoko Mine, Haruka Ishibashi, Takamichi Sugimoto, Eiichi Nomura, Takemori Yamawaki (Department of neurology in Hiroshima city Hiroshima citizens hospital)
Natsuko Kato1,3, Kanako Muraga7, Yoshihiro Hirata1, Akihiro Shindo1, Keita Matsuura1, Yuichiro Ii1, Mariko Shiga2, Ken-ichi Tabei3, Masayuki Satoh2,3, Hidekazu Tomimoto1,2, Satoshi Fujita4, Yoshihiko Kagawa4, Eitaro Fujii4, Masaaki Ito4, Maki Umino5, Masayuki Maeda5,6 (1.Department of Neurology, Grauate School of Medicine, Mie University, 2.core-type Medical Center for Dementia, Mie Prefecture, 3.Department of Dementia Prevention and Therapeutics, Graduate School of Medicine, Mie University, 4.Department of Cardiology and nephrology, Grauate School of Medicine, Mie University, 5.Department of Radiology, Grauate School of Medicine, Mie University, 6.Department of Advanced Diagnostic Imaging, Grauate School of Medicine, Mie University, 7.Department of Neurologic Science, Grauate School of Medicine, Nippon Medical School)